Julien de Salaberry is a healthcare change catalyst, entrepreneur, and author with over 25 years of experience in the industry. He has worked with leading brands such as Eli Lilly, Boston Scientific, Baxter, GSK, and Merck&Co. His expertise lies in organic and inorganic growth in healthcare, particularly in emerging markets. He founded Galen Growth, a global leader in digital health intelligence, analytics, and matchmaking, which empowers Fortune 500 corporations and institutional investors. Julien is also the Founder of The Propell Group, a successful boutique venture investor based in Singapore. He co-founded the Global Cancer Research & Commercialization Fund in 2016, an initiative aimed at harnessing technology and business model innovation to drive better outcomes for cancer patients.

Apart from his entrepreneurial ventures, Julien is also an author and regular host and speaker on HealthTech / Digital Health Innovation and Disruption. His latest book, Living in the Age of the Jerk, deals with the impact of technological changes brought by the Fourth and Fifth Industrial Revolutions on humans, our environment, and society.

With an educational background that includes a BEng from the University of Portsmouth, BUBS from INSEAD, and an MBA from Cranfield School of Management, Julien has a deep understanding of healthcare across Europe, the Middle East, and Asia.